Phase 2 Study Comparing Efficacy and Safety of ABT-165 plus FOLFIRI vs Bevacizumab plus FOLFIRI in Metastatic Colorectal Cancer Previously Treated with Fluoropyrimidine/Oxaliplatin and Bevacizumab
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
AbbVie Inc.
Start Date
May 21, 2018
End Date
March 30, 2021
Administered By
Duke Cancer Institute
Awarded By
AbbVie Inc.
Start Date
May 21, 2018
End Date
March 30, 2021